INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. INSP has an excellent financial health rating, but there are some minor concerns on its profitability. INSP is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes INSP very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
INSP had negative earnings in 4 of the past 5 years.
In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
INSP has a Return On Assets of 9.10%. This is amongst the best in the industry. INSP outperforms 91.98% of its industry peers.
INSP has a Return On Equity of 10.46%. This is amongst the best in the industry. INSP outperforms 85.03% of its industry peers.
INSP has a Return On Invested Capital of 6.83%. This is amongst the best in the industry. INSP outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 10.46% | ||
| ROIC | 6.83% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of INSP (7.92%) is better than 80.75% of its industry peers.
With a decent Operating Margin value of 5.93%, INSP is doing good in the industry, outperforming 71.12% of the companies in the same industry.
INSP has a better Gross Margin (84.65%) than 94.65% of its industry peers.
In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 7.92% | ||
| GM | 84.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
INSP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INSP has more shares outstanding
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INSP has an Altman-Z score of 18.02. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
INSP has a Altman-Z score of 18.02. This is amongst the best in the industry. INSP outperforms 94.65% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.02 |
ROIC/WACC0.77
WACC8.86%
2.3 Liquidity
INSP has a Current Ratio of 9.01. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of INSP (9.01) is better than 90.37% of its industry peers.
INSP has a Quick Ratio of 7.44. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of INSP (7.44) is better than 89.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.01 | ||
| Quick Ratio | 7.44 |
3. Growth
3.1 Past
INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1177.78%, which is quite impressive.
INSP shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.49%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.83%
3.2 Future
Based on estimates for the next years, INSP will show a very strong growth in Earnings Per Share. The EPS will grow by 33.18% on average per year.
Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 15.93% on average per year.
EPS Next Y33.65%
EPS Next 2Y38.12%
EPS Next 3Y38.5%
EPS Next 5Y33.18%
Revenue Next Year18.72%
Revenue Next 2Y18.02%
Revenue Next 3Y17.47%
Revenue Next 5Y15.93%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 33.83, INSP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 70.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, INSP is valued a bit more expensive.
INSP is valuated rather expensively with a Price/Forward Earnings ratio of 23.58.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 73.80% of the companies are valued more expensively.
INSP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.83 | ||
| Fwd PE | 23.58 |
4.2 Price Multiples
69.52% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than 79.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.1 | ||
| EV/EBITDA | 32.58 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
INSP has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INSP's earnings are expected to grow with 38.50% in the coming years.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y38.12%
EPS Next 3Y38.5%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:INSP (8/6/2025, 2:12:02 PM)
77.81
-10.1 (-11.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.63%
Inst Owner Change-0.35%
Ins Owners0.94%
Ins Owner Change1%
Market Cap2.29B
Analysts79.23
Price Target177.91 (128.65%)
Short Float %11.82%
Short Ratio5.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)96.78%
Min EPS beat(2)54.07%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)299.97%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)246.43%
EPS beat(12)12
Avg EPS beat(12)179.1%
EPS beat(16)16
Avg EPS beat(16)144.99%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)1.13%
Revenue beat(4)3
Avg Revenue beat(4)0.62%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.36%
Revenue beat(8)5
Avg Revenue beat(8)1.1%
Revenue beat(12)9
Avg Revenue beat(12)3.88%
Revenue beat(16)13
Avg Revenue beat(16)5.01%
PT rev (1m)-0.53%
PT rev (3m)-4.74%
EPS NQ rev (1m)-1.41%
EPS NQ rev (3m)-49.77%
EPS NY rev (1m)0%
EPS NY rev (3m)4.6%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-6.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.83 | ||
| Fwd PE | 23.58 | ||
| P/S | 2.73 | ||
| P/FCF | 29.1 | ||
| P/OCF | 20.01 | ||
| P/B | 3.61 | ||
| P/tB | 3.61 | ||
| EV/EBITDA | 32.58 |
EPS(TTM)2.3
EY2.96%
EPS(NY)3.3
Fwd EY4.24%
FCF(TTM)2.67
FCFY3.44%
OCF(TTM)3.89
OCFY5%
SpS28.49
BVpS21.56
TBVpS21.56
PEG (NY)1.01
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.1% | ||
| ROE | 10.46% | ||
| ROCE | 7.46% | ||
| ROIC | 6.83% | ||
| ROICexc | 15.3% | ||
| ROICexgc | 15.3% | ||
| OM | 5.93% | ||
| PM (TTM) | 7.92% | ||
| GM | 84.65% | ||
| FCFM | 9.39% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score9
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 409.3% | ||
| Cap/Sales | 4.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 195.8% | ||
| Profit Quality | 118.56% | ||
| Current Ratio | 9.01 | ||
| Quick Ratio | 7.44 | ||
| Altman-Z | 18.02 |
F-Score9
WACC8.86%
ROIC/WACC0.77
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y33.65%
EPS Next 2Y38.12%
EPS Next 3Y38.5%
EPS Next 5Y33.18%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.83%
Revenue Next Year18.72%
Revenue Next 2Y18.02%
Revenue Next 3Y17.47%
Revenue Next 5Y15.93%
EBIT growth 1Y238.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year687.25%
EBIT Next 3Y123.87%
EBIT Next 5Y84.08%
FCF growth 1Y594.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y399.06%
OCF growth 3YN/A
OCF growth 5YN/A